tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
:NNNN
US Market

Anbio Biotechnology Class A (NNNN) Ratios

Compare
21 Followers

Anbio Biotechnology Class A Ratios

NNNN's free cash flow for Q4 2024 was $0.85. For the 2024 fiscal year, NNNN's free cash flow was decreased by $ and operating cash flow was $-0.52. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
10.71 15.86 9.88 2.07
Quick Ratio
10.71 15.86 9.63 2.07
Cash Ratio
6.80 9.76 5.03 1.76
Solvency Ratio
1.37 2.28 7.10 1.07
Operating Cash Flow Ratio
1.20 0.90 3.15 1.76
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00
Net Current Asset Value
$ 16.80M$ 14.76M$ 12.53M$ 2.54M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.10 1.07 1.11 1.94
Debt Service Coverage Ratio
0.00 0.00 1.25K 0.00
Interest Coverage Ratio
0.00 0.00 1.27K 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 <0.01 0.00
Net Debt to EBITDA
-4.58 -3.95 -0.71 -1.65
Profitability Margins
Gross Profit Margin
71.90%50.07%53.36%57.40%
EBIT Margin
28.99%33.58%42.55%57.26%
EBITDA Margin
31.36%36.50%42.58%57.26%
Operating Profit Margin
24.38%29.22%43.30%55.46%
Pretax Profit Margin
28.99%33.58%42.52%57.26%
Net Profit Margin
28.99%33.58%42.52%57.26%
Continuous Operations Profit Margin
28.99%33.58%42.52%57.26%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
118.92%114.93%98.19%103.25%
Return on Assets (ROA)
12.54%14.25%71.72%51.59%
Return on Equity (ROE)
13.80%15.21%79.79%100.00%
Return on Capital Employed (ROCE)
11.61%13.23%81.26%96.85%
Return on Invested Capital (ROIC)
11.61%13.23%81.26%96.85%
Return on Tangible Assets
12.54%14.25%71.72%51.59%
Earnings Yield
0.97%0.27%1.21%0.44%
Efficiency Ratios
Receivables Turnover
7.69 3.56 6.57K 6.17
Payables Turnover
1.42 4.05 7.80 1.00
Inventory Turnover
0.00 0.00 31.03 0.00
Fixed Asset Turnover
0.00 0.00 1.95K 0.00
Asset Turnover
0.43 0.42 1.69 0.90
Working Capital Turnover Ratio
0.52 0.49 3.13 0.00
Cash Conversion Cycle
-210.47 12.41 -34.98 -306.51
Days of Sales Outstanding
47.48 102.50 0.06 59.14
Days of Inventory Outstanding
0.00 0.00 11.76 0.00
Days of Payables Outstanding
257.95 90.09 46.80 365.65
Operating Cycle
47.48 102.50 11.82 59.14
Cash Flow Ratios
Operating Cash Flow Per Share
0.05 <0.01 0.03 0.04
Free Cash Flow Per Share
0.05 <0.01 0.03 0.04
CapEx Per Share
0.00 0.00 <0.01 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 1.54M 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 1.54M 0.00
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.25 0.13 0.19 0.94
Free Cash Flow Yield
0.85%0.11%0.54%0.72%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
102.84 368.39 82.93 227.54
Price-to-Sales (P/S) Ratio
29.81 123.70 35.26 130.29
Price-to-Book (P/B) Ratio
14.19 56.03 66.17 227.54
Price-to-Free Cash Flow (P/FCF) Ratio
117.30 924.18 186.62 137.99
Price-to-Operating Cash Flow Ratio
117.30 924.18 186.62 137.99
Price-to-Earnings Growth (PEG) Ratio
0.40 -4.76 0.48 0.00
Price-to-Fair Value
14.19 56.03 66.17 227.54
Enterprise Value Multiple
90.49 334.99 82.11 225.89
Enterprise Value
232.26M 820.56M 823.15M 572.82M
EV to EBITDA
90.49 334.99 82.11 225.89
EV to Sales
28.38 122.25 34.96 129.35
EV to Free Cash Flow
111.64 913.40 185.03 136.99
EV to Operating Cash Flow
111.64 913.40 185.03 136.99
Tangible Book Value Per Share
0.41 0.10 0.09 0.03
Shareholders’ Equity Per Share
0.41 0.10 0.09 0.03
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00
Revenue Per Share
0.19 0.05 0.16 0.04
Net Income Per Share
0.06 0.02 0.07 0.03
Tax Burden
1.00 1.00 1.00 1.00
Interest Burden
1.00 1.00 1.00 1.00
Research & Development to Revenue
0.06 0.02 <0.01 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00
Income Quality
0.88 0.40 0.44 1.65
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis